Article
Reactivation capacity by latency-reversing agents ex vivo correlates with the size of the HIV-1 reservoir
15 Oct 2016
Abstract excerpt
OBJECTIVE: HIV-1 reservoirs are the major hurdle to virus clearance in combination antiretroviral therapy (cART)-treated patients. An approach to eradicating HIV-1 involves reversing latency in cART-treated patients to make latent cells visible to the host immune system. Stimulation of patient cell cultures with latency-reversing agents (LRAs) ex vivo results in heterogeneous responses among HIV-infected...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
